Pneumococcal Vaccines Market Trends, Market Research Analysis, and Projections
Pneumococcal Vaccines Market Pneumococcal disease is caused by the bacteria streptococcus pneumonia (also known as pneumococcus). Pneumococcus infections can occur in the blood, lungs, and brain. Cough, chest pain, fever, rapid breathing are some of the symptoms of pneumococcal disease. The pneumococcal disease spreads from person to person and causes a variety of health issues. There are two kinds of pneumococcal vaccines on the market: pneumococcal conjugate vaccines (PCV13 vaccine) and pneumococcal polysaccharide vaccines (PPSV23 vaccine). The PCV13 vaccine is approved for use in the immunization of infants, older adults, and people with certain medical conditions. PPSV23 vaccine, on the other hand, is only approved for people over the age of two. Currently, the only vaccines available for childhood protection are pneumococcal conjugate vaccines. Pneumococcal vaccines will be more widely used as patient awareness of pneumococcal disease treatment grows. The...